IN2012DN00324A - - Google Patents
Info
- Publication number
- IN2012DN00324A IN2012DN00324A IN324DEN2012A IN2012DN00324A IN 2012DN00324 A IN2012DN00324 A IN 2012DN00324A IN 324DEN2012 A IN324DEN2012 A IN 324DEN2012A IN 2012DN00324 A IN2012DN00324 A IN 2012DN00324A
- Authority
- IN
- India
- Prior art keywords
- proteins
- encapsidation
- capsids
- rna
- viral
- Prior art date
Links
- 210000000234 capsid Anatomy 0.000 abstract 3
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 101710094648 Coat protein Proteins 0.000 abstract 1
- 101710139375 Corneodesmosin Proteins 0.000 abstract 1
- 241000723655 Cowpea mosaic virus Species 0.000 abstract 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 abstract 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 101710141454 Nucleoprotein Proteins 0.000 abstract 1
- 108010076039 Polyproteins Proteins 0.000 abstract 1
- 101710083689 Probable capsid protein Proteins 0.000 abstract 1
- 108020000999 Viral RNA Proteins 0.000 abstract 1
- 241001493065 dsRNA viruses Species 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/18011—Comoviridae
- C12N2770/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/18011—Comoviridae
- C12N2770/18023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18697009P | 2009-06-15 | 2009-06-15 | |
| PCT/GB2010/001183 WO2010146359A1 (en) | 2009-06-15 | 2010-06-15 | Production of viral capsids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00324A true IN2012DN00324A (instruction) | 2015-05-08 |
Family
ID=42732569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN324DEN2012 IN2012DN00324A (instruction) | 2009-06-15 | 2010-06-15 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20120174263A1 (instruction) |
| EP (1) | EP2443241A1 (instruction) |
| CA (1) | CA2765357A1 (instruction) |
| IN (1) | IN2012DN00324A (instruction) |
| WO (1) | WO2010146359A1 (instruction) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX358762B (es) | 2011-12-21 | 2018-09-03 | Apse Llc | Procesos que utilizan vlps con cápsides resistentes a hidrolasas. |
| EP3789017A1 (en) * | 2013-06-19 | 2021-03-10 | Apse Llc | Compositions and methods using capsids resistant to hydrolases |
| US10392615B2 (en) * | 2015-06-26 | 2019-08-27 | The Regents Of The University Of California | Methods for RNA promoter identification |
| EP3141600A1 (en) * | 2015-09-11 | 2017-03-15 | Institut National de la Recherche Agronomique | Nepovirus coat protein fusion polypeptides and their use |
| CN111262657B (zh) * | 2020-01-16 | 2022-05-20 | 重庆大学 | 通过gatt和数据分割重组来适配的通信方法及系统 |
| WO2023049983A1 (en) * | 2021-09-28 | 2023-04-06 | Medicago Inc. | Cpmv vlps displaying sars-cov-2 epitopes |
| WO2024233406A2 (en) * | 2023-05-05 | 2024-11-14 | The Regents Of The University Of California | Cpmv-rna immunotherapy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8200523A (nl) | 1982-02-11 | 1983-09-01 | Univ Leiden | Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna. |
| EP0116718B2 (en) | 1983-01-13 | 1996-05-08 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid Ti plasmid vectors useful for this process |
| CA1280081C (en) | 1984-09-24 | 1991-02-12 | Calgene, Inc. | Plant cell microinjection technique |
| US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
| CA1288073C (en) | 1985-03-07 | 1991-08-27 | Paul G. Ahlquist | Rna transformation vector |
| AU7360087A (en) | 1986-04-30 | 1987-11-24 | Boyce Thompson Institute For Plant Research Inc. | Electric field mediated dna transformation of plant cells and organelles |
| US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
| NZ224470A (en) | 1987-05-05 | 1991-06-25 | Sandoz Ltd | Method of transforming plant cell material; plant cell material and plants |
| FI890917A7 (fi) | 1988-03-02 | 1989-09-03 | Schweizerische Eidgenossenschaft | Menetelmä transgeenisten kasvien valmistamiseksi |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| DE59009881D1 (de) | 1989-12-19 | 1995-12-21 | Ciba Geigy Ag | Verfahren und Vorrichtung zur genetischen Transformation von Zellen. |
| DE4005152A1 (de) | 1990-02-17 | 1991-08-22 | Guenter Prof Dr Kahl | Verbesserung der transformation von pflanzenzellen |
| CA2036935A1 (en) | 1990-02-26 | 1991-08-27 | Paul Christou | Plant transformation process with early identification of germ line transformation events |
| NZ239977A (en) | 1990-11-14 | 1993-08-26 | Pioneer Hi Bred Int | Transforming plants by the use of agrobacterium |
| US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
| DK0558676T3 (da) | 1990-11-23 | 2000-09-25 | Aventis Cropscience Nv | Fremgangsmåde til transformering af enkimbladede planter |
| AU4539593A (en) | 1992-06-23 | 1994-01-24 | South Dakota State University | Transformation of plants by direct injection of dna |
| BRPI0417159A (pt) * | 2003-12-01 | 2007-03-06 | Dow Global Technologies Inc | produção de partìcula semelhante a vìrus icosaédrico recombinante em pseudomÈnades |
| WO2007135480A1 (en) | 2006-05-22 | 2007-11-29 | Plant Bioscience Limited | Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants |
-
2010
- 2010-06-15 US US13/378,347 patent/US20120174263A1/en not_active Abandoned
- 2010-06-15 WO PCT/GB2010/001183 patent/WO2010146359A1/en active Application Filing
- 2010-06-15 EP EP10727484A patent/EP2443241A1/en not_active Withdrawn
- 2010-06-15 IN IN324DEN2012 patent/IN2012DN00324A/en unknown
- 2010-06-15 CA CA2765357A patent/CA2765357A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120174263A1 (en) | 2012-07-05 |
| CA2765357A1 (en) | 2010-12-23 |
| WO2010146359A1 (en) | 2010-12-23 |
| EP2443241A1 (en) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00324A (instruction) | ||
| Sainsbury | Innovation in plant-based transient protein expression for infectious disease prevention and preparedness | |
| WO2006119516A3 (en) | Expression of viral proteins in plants | |
| MX2023009081A (es) | Metodos para detectar aav. | |
| MX2014007516A (es) | Procesos que utilizan vlps con capsides resistentes a hidrolasas. | |
| WO2007047831A3 (en) | Functional influenza virus like particles (vlps) | |
| MX2019006467A (es) | Composiciones y métodos para mejorar la expresión génica. | |
| Jutras et al. | Modulating secretory pathway pH by proton channel co‐expression can increase recombinant protein stability in plants | |
| WO2008148104A8 (en) | Novel vlps derived from cells that do not express a viral matrix or core protein | |
| WO2010144058A8 (en) | Virus induced gene silencing (vigs) for functional analysis of genes in cotton. | |
| MX2012001075A (es) | Vectores lentivirales pseudotipificados con una glicoproteina de envoltura de virus sindbis. | |
| IN2012DN03093A (instruction) | ||
| EA201201025A1 (ru) | Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них | |
| ZA202100384B (en) | Influenza virus hemagglutinin mutants | |
| WO2011056899A3 (en) | Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps | |
| NZ592979A (en) | Bovine viral diarrhea virus with a modified erns protein | |
| SG10201805197VA (en) | Compositions and methods using capsids resistant to hydrolases | |
| WO2015038915A3 (en) | Compositions and methods using capsids resistant to hydrolases | |
| WO2009082085A3 (en) | Highly infectious nucleic acid molecules from pepper mottle virus and plant viral vector derived from the same | |
| MX2014003508A (es) | Vectores basados en el virus de la tristeza de los cítricos para la expresion de gen/es ajenos. | |
| WO2007144886A3 (en) | Virus-like particles for treatment of viral infections | |
| WO2010009465A3 (en) | Htlv-ii vector and methods of use | |
| WO2009131423A3 (ko) | 신규 ａ형 간염 바이러스의 항원 유전자 및 상기 유전자로 형질전환된 식물체 | |
| MX385484B (es) | Vlps derivadas de virus de planta con dsrna encapsidado y metodo de sintesis. | |
| MX2025001858A (es) | Virus de la gripe modificados |